Nutrition and NSCLC; Should we Administer Food Supplements?

(E-pub Ahead of Print)

Author(s): Paul Zarogoulidis*, Christoforos Kosmidis, Isaak Kesisoglou, Kosmas Tsakiridis, Wolfgang Hohenforst-Schmidt, Haidong Huang, Κonstantinos Romanidis, Anastasios Vagionas, Konstantinos Sapalidis

Journal Name: Current Pharmaceutical Design


Become EABM
Become Reviewer
Call for Editor

Abstract:

Non-small cell lung cancer is usually diagnosed at advanced stage disease. We have novel diagnostic tools, however; prevention is still the best way to idetify this disease. Patients receive different treatments with different adverse effects. Targeted traetment with tyrosine kinase inhibitors, and immunotherapy have entered everyday clinical practice. The nutritional status of a patient plays a crucial role in the treatment of a patient. Cahexia is observed in most cancer patients and it has been identyfied as an independent factor to the overall survival of a patient. The improvement of nutritional status and metabolism, has direct impact to the quality of life, daily living and overall survival of a lung cancer patient. We have conducted a search on pub med and scopus and identified relevant publications. In this review we will focus on the nutritional status of nsclc patients and how food supplements assist in the QoL based on published literature. Additional information from other cancer types will be included where necessary.

Keywords: NSCLC, nutrition, immunotherapy, chemotherapy, tyrosine kinase inhibitors, cancer

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Ahead of Print)
DOI: 10.2174/1381612827999210111193133
Price: $95

Article Metrics

PDF: 74